Can our experience with surveillance for inherited pancreatic cancer help to identify early pancreatic cancer in the general population?
Fam Cancer
; 23(3): 399-403, 2024 Aug.
Article
em En
| MEDLINE
| ID: mdl-38441833
ABSTRACT
Screening of the general population for cancer is a matter of primary prevention reducing the burden of disease. Whilst this is successful for several cancers including breast, colon and prostate, the situation to screen and hence prevent pancreatic cancer is different. The organ is not as accessible to simple physical exam or biological samples (fecal or blood test). Neither exists a blood test such as PSA that is cost-effective. Reviewing the evidence from screening risk groups for pancreatic cancer, one must conclude that there is no rational at present to screen the general population, for a lack of appropriate tests.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Pancreáticas
/
Detecção Precoce de Câncer
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article